Regenerative Medicine Stocks
Biotechnology and medical device firms in this sector develop therapies designed to replace, engineer, or regenerate human cells, tissues, and organs to restore normal function. Revenue models hinge on proprietary cell-processing platforms, bio-printed scaffolds, and specialized cold-chain logistics essential for maintaining biological integrity during transport.
As of Oct 23, 2026, Regenerative Medicine has 50 US-listed companies worth $41.6B combined. The median member moved +0.8% over the past week; RCEL led among the 25 largest at +18.9% and SLBT trailed at -24.8%.
Companies in Regenerative Medicine
- UTHR – United Therapeutics Corporation, $25.1B
- AXGN – Axogen Inc, $2.2B
- VCEL – Vericel Corp Ord, $2.1B
- BLFS – BioLife Solutions Inc, $1.9B
- MESO – Mesoblast Ltd, $1.7B
- IART – Integra LifeSciences Holdings, $1B
- SLBT – SL Science Holding Limited Ordinary Shares, $869M
- PROK – ProKidney Corp., $695M
- MDXG – MiMedx Group Inc, $670M
- AVR – Anteris Technologies Global Corp. Common Stock, $629M
- DDD – 3D Systems Corporation, $557M
- AGMB – AgomAb Therapeutics NV American Depositary Shares, $422M
- RCEL – Avita Medical Ltd, $404M
- CAPR – Capricor Therapeutics Inc, $384M
- OFIX – Orthofix Medical Inc, $367M
- SMTI – Sanara Medtech Inc, $320M
- SRZN – Surrozen Inc, $276M
- ANIK – Anika Therapeutics Inc, $256M
- LCTX – Lineage Cell Therapeutics Inc, $251M
- FATE – Fate Therapeutics Inc, $231M
- LXEO – Lexeo Therapeutics, Inc. Common Stock, $217M
- ORGO – Organogenesis Holdings Inc, $170M
- NGEN – NervGen Pharma Corp., $166M
- MSLE – Satellos Bioscience Inc. Common Stock, $145M
- HUMA – Humacyte Inc, $119M
- CNXU – Conexeu Sciences Inc. Common Stock, $93.4M
- TNYA – Tenaya Therapeutics Inc, $87.5M
- TELO – Telomir Pharmaceuticals, Inc. Common Stock, $80.2M
- CELU – Celularity Inc, $44.8M
- SNWV – SANUWAVE Health, Inc. Common Stock, $43.4M
- CCEL – CryoCell International Inc, $38.3M
- NCEL – NewcelX Ltd., $16.5M
- BCDA – Biocardia Inc, $15.7M
- PLUR – Pluri Inc., $12.5M
- GDTC – CytoMed Therapeutics Limited Ordinary Shares, $11.1M
- BIOT – Instinct Bio Technical Company Holdings Inc. Ordinary Shares, $11M
- RGNT – Regentis Biomaterials Ltd., $10.3M
- BCLI – Brainstorm Cell Therapeutics Inc, $9.2M
- FBLG – FibroBiologics, Inc. Common Stock, $8M
- CLGN – Collplant Biotechnologies Ltd, $7.4M
- SNTI – Senti Biosciences Inc, $7.1M
- CELZ – Creative Medical Technology Holdings Inc, $6.4M
- LGVN – Longeveron LLC, $5.1M
- KALA – Kala Pharmaceuticals Inc, $3.7M
- ORGS – Orgenesis Inc, $3.4M
- BRTX – BioRestorative Therapies Inc, $3.1M
- BBLG – Bone Biologics Corp, $1.1M
- XAGE – Longevity Health Holdings, Inc., $277,235
- BACK – IMAC Holdings Inc, $2,270
- THMO – Thermogenesis Holdings Inc, $1,584